News
Drug Shortage Impact - PLEASE Share Your Stories!
Help ASCO help us with legislation changes!
Details >ASCO's Practice Impact Analysis of 2024 Medicare Physician Fee Schedule Proposed Rule
Details >Join OHOS in Supporting House Bill 130!
Prior Authorization Gold Card Program
Details >HHS Selects the First Drugs for Medicare Drug Price Negotiation
Details >A September Message From OHOS Lobbyist, Matt Whitehead
This is a must read!!
Details >Physician Fee Schedule Proposed Rule Cuts Radiation Oncology Services by 2%
ASTRO Leaders See Cuts to Radiation Therapy Services Hitting Patient Access
Details >An August Message From OHOS Lobbyist, Matt Whitehead
Includes important information on the August 8th election!
Details >What Happened to Ohio's Co-Pay Accumulator Bill?
Details >ASCO in Action - Comments on Release of 2024 OPPS and PFS Proposed Rules
Physician Fee Schedule Conversion Factor Cut to 3.36%
Details >CMS Physician Fee Schedule and Outpatient Hospital Proposed Rules Released!
Details >ASTRO Releases New Radiation Oncology Payment Reform Legislative Proposal
Town Hall on July 21st for Radiation Oncology Community
Details >CMS Announces Actions to Lower Health Care Costs and Allow Medicare to Negotiate Lower Drug Prices
Details >A July Message From OHOS Lobbyist, Matt Whitehead
An update about White-Bagging, Prior Authorizations, Biomarker Testing, Copay Accumulator Bills and so much more!
Details >OHOS Regional Spring Meeting Roundtables
A Great Success That Has Ignited Many OHOS Initiatives!
Details >COA - Statement on CMS Failure to Rescind FAQ Barring Oncology Practices from Delivering Cancer Drugs to Their Patients
Details >DELAYED - New CIGNA Reimbursement Policy on Modifier 25
Details >CNBC - FDA Allows Temporary Import of Unapproved Chinese Cancer Drug to Ease US Shortage
Details >ASCO - National Shortage of Cancer Drugs Updates
Guidance for Clinicians on GI Cancer, Recommendations to Policymakers, Dedicated Drug Shortages Website
Details >A June Message From OHOS Lobbyist, Matt Whitehead
An update about Prior Authorizations, Biomarker Testing, Copay Accumulator Bills and so much more!
Details >OHOS Supports the "Safe Step Act" Legislation
Ensures that employer health plans and pharmacy benefit managers (PBMs) provide an expedient and medically reasonable step therapy exceptions process.
Details >Practices Ask HHS Secretary Becerra and Congress for Stark Law Fix
Details >2024 Medicare Advantage, Part D Final Rule Addresses Prior Authorization, Equity and Affordability
Details >HHS Notice of Benefit and Payment Parameters for 2024
Details >New House Bill Aims to Help Stabilize Medicare Physician Reimbursement, Patient Access to Care
Details >Cancer Doctors Call on Congress to Reduce Barriers to Care and Support Cancer Research
Details >A May Message From OHOS Lobbyist, Matt Whitehead
An update about Prior Authorizations, Biomarker Testing, Copay Accumulator Bills and so much more!
Details >Ohio Bill Seeks to Get Coverage for Biomarker Testing Under Insurance Companies
Details >HHS Releases National Cancer Plan
Details >Shortages of 4 Drugs May Complicate Cancer Care
Includes methotrexate, cisplatin and fluorouracil
Details >Ohio Attorney General, David Yost, Sues Express Scripts, Prime Therapeutics and 5 Others, Blaming Exorbitant Drug Prices on Their Collusion
Details >Reduced Beneficiary Coinsurance for 27 Part B Drugs in Effect April 1st - Includes Cancer Drugs
Details >HHS Updates 2024 Medicare Advantage Program and Part D Payment Policies
Details >An April Message From OHOS Lobbyist, Matt Whitehead
An update about Prior Authorizations, Biomarker Testing, Copay Accumulator Bills and more!
Details >